TY - JOUR
T1 - Signaling factors in the mechanism of ammonia neurotoxicity
AU - Norenberg, M. D.
AU - Rama Rao, K. V.
AU - Jayakumar, A. R.
N1 - Funding Information:
Acknowledgments This work was supported by a Merit Review from the Department of Veterans Affairs and by National Institutes of Health Grant DK063311. A.R.J is supported by the American Association for the Study of Liver Disease/American Liver Foundation Grant. We thank Max Norenberg for helpful contributions.
PY - 2009/3
Y1 - 2009/3
N2 - Mechanisms involved in hepatic encephalopathy (HE) still remain poorly understood. It is generally accepted that ammonia plays a major role in this disorder, and that astrocytes represent the principal target of ammonia neurotoxicity. In recent years, studies from several laboratories have uncovered a number of factors and pathways that appear to be critically involved in the pathogenesis of this disorder. Foremost is oxidative and nitrosative stress (ONS), which is largely initiated by an ammonia-induced increase in intracellular Ca2+. Such increase in Ca2+ activates a number of enzymes that promote the synthesis of reactive oxygen-nitrogen species, including constitutive nitric oxide synthase, NADPH oxidase and phospholipase A2. ONS subsequently induces the mitochondrial permeability transition, and activates mitogen-activated protein kinases and the transcription factor, nuclear factor-kappaB (NF-κB). These factors act to generate additional reactive oxygen-nitrogen species, to phosphorylate various proteins and transcription factors, and to cause mitochondrial dysfunction. This article reviews the role of these factors in the mechanism of HE and ammonia toxicity with a focus on astrocyte swelling and glutamate uptake, which are important consequences of ammonia neurotoxicity. These pathways and factors provide attractive targets for identifying agents potentially useful in the therapy of HE and other hyperammonemic disorders.
AB - Mechanisms involved in hepatic encephalopathy (HE) still remain poorly understood. It is generally accepted that ammonia plays a major role in this disorder, and that astrocytes represent the principal target of ammonia neurotoxicity. In recent years, studies from several laboratories have uncovered a number of factors and pathways that appear to be critically involved in the pathogenesis of this disorder. Foremost is oxidative and nitrosative stress (ONS), which is largely initiated by an ammonia-induced increase in intracellular Ca2+. Such increase in Ca2+ activates a number of enzymes that promote the synthesis of reactive oxygen-nitrogen species, including constitutive nitric oxide synthase, NADPH oxidase and phospholipase A2. ONS subsequently induces the mitochondrial permeability transition, and activates mitogen-activated protein kinases and the transcription factor, nuclear factor-kappaB (NF-κB). These factors act to generate additional reactive oxygen-nitrogen species, to phosphorylate various proteins and transcription factors, and to cause mitochondrial dysfunction. This article reviews the role of these factors in the mechanism of HE and ammonia toxicity with a focus on astrocyte swelling and glutamate uptake, which are important consequences of ammonia neurotoxicity. These pathways and factors provide attractive targets for identifying agents potentially useful in the therapy of HE and other hyperammonemic disorders.
KW - Ammonia
KW - Astrocytes
KW - Hepatic encephalopathy
KW - Mitochondrial permeability transition
KW - Mitogen-activated protein kinases
KW - NF-κB
KW - Oxidative/nitrosative stress
UR - http://www.scopus.com/inward/record.url?scp=60449101891&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=60449101891&partnerID=8YFLogxK
U2 - 10.1007/s11011-008-9113-6
DO - 10.1007/s11011-008-9113-6
M3 - Review article
C2 - 19104923
AN - SCOPUS:60449101891
SN - 0885-7490
VL - 24
SP - 103
EP - 117
JO - Metabolic Brain Disease
JF - Metabolic Brain Disease
IS - 1
ER -